Vancouver, British Columbia – September 11, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB), (the “Company”) is pleased to announce that the Company's shares have been accepted for continuous trading on the German electronic trading platform Xetra® under the ticker symbol "ZSB.DE". The International Security Identification Number (ISIN) is CA82967M1005.
The electronic trading system Xetra® is utilized to trade approximately 300,000 international instruments. Xetra® has a market share of over 90 percent in equity trading and is one of the fastest trading systems in the world with a round-trip-time at only two milliseconds. Financial institutions, securities trading houses and brokers can participate in Xetra® trading. Xetra® operates independently of the trader's location, permitting international participation. In fact, more than 130 participants from European countries outside Germany trade on Xetra®.
Sirona Biochem has appointed Hauck & Aufhäuser Privatbankiers KGaA (H&A) as its designated sponsor on Xetra®. The designated sponsor will work to facilitate higher liquidity in stock trading of Sirona common shares by maintaining a constant quotation volume (minimum trade volume) to ensure tradability is guaranteed - even in highly volatile market periods.
Dr. Howard Verrico, CEO and Chairman of Sirona Biochem, stated, "The Xetra® listing marks a further step in Sirona's commitment to its shareholders to enhance the liquidity of the Company's common shares and is one of many initiatives we are taking to further increase market awareness. A generally visible valuation discount due to limited liquidity will be reduced and therefore should generate an increased interest of institutional investors. Several potential European investors have confirmed that a continuous Xetra® listing will make it easier for them to invest in Sirona. We are proud that, from our point of view, the best Xetra® specialist team in Germany has chosen Sirona as a new client."
About Hauck & Aufhäuser Privatbankiers KGaA
Hauck & Aufhäuser Privatbankiers is one of the few independent private banks in Germany and can look back on over 219 years of tradition. The bank resulted from the 1998 merger of two highly traditional private banks: Georg Hauck & Sohn Bankiers, founded in Frankfurt am Main in 1796, and Bankhaus H. Aufhäuser, which opened its doors in Munich in 1870.
From its locations in Frankfurt am Main, Munich, Hamburg, Düsseldorf and Cologne, the bank focuses on providing comprehensive advisory services and administering the assets of its private, corporate and institutional clients. This includes asset management for institutional investors, close cooperation with independent asset managers and both the concept and management of private label funds.
The partners of the bank consist of the personally liable partner, Jochen Lucht, and the partners, Michael O. Bentlage and Stephan Rupprecht. All of the bank’s capital is in the hands of private investors. Hauck & Aufhäuser considers itself a private bank that combines modernity with a strong sense of tradition. The focus of its business activities is on providing comprehensive and personalized advisory services, which form the basis for developing customized solutions. For more information visit: www.hauck-aufhaeuser.de.
For more information regarding this press release, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
Help employers find you! Check out all the jobs and post your resume.
The electronic trading system Xetra® is utilized to trade approximately 300,000 international instruments. Xetra® has a market share of over 90 percent in equity trading and is one of the fastest trading systems in the world with a round-trip-time at only two milliseconds. Financial institutions, securities trading houses and brokers can participate in Xetra® trading. Xetra® operates independently of the trader's location, permitting international participation. In fact, more than 130 participants from European countries outside Germany trade on Xetra®.
Sirona Biochem has appointed Hauck & Aufhäuser Privatbankiers KGaA (H&A) as its designated sponsor on Xetra®. The designated sponsor will work to facilitate higher liquidity in stock trading of Sirona common shares by maintaining a constant quotation volume (minimum trade volume) to ensure tradability is guaranteed - even in highly volatile market periods.
Dr. Howard Verrico, CEO and Chairman of Sirona Biochem, stated, "The Xetra® listing marks a further step in Sirona's commitment to its shareholders to enhance the liquidity of the Company's common shares and is one of many initiatives we are taking to further increase market awareness. A generally visible valuation discount due to limited liquidity will be reduced and therefore should generate an increased interest of institutional investors. Several potential European investors have confirmed that a continuous Xetra® listing will make it easier for them to invest in Sirona. We are proud that, from our point of view, the best Xetra® specialist team in Germany has chosen Sirona as a new client."
About Hauck & Aufhäuser Privatbankiers KGaA
Hauck & Aufhäuser Privatbankiers is one of the few independent private banks in Germany and can look back on over 219 years of tradition. The bank resulted from the 1998 merger of two highly traditional private banks: Georg Hauck & Sohn Bankiers, founded in Frankfurt am Main in 1796, and Bankhaus H. Aufhäuser, which opened its doors in Munich in 1870.
From its locations in Frankfurt am Main, Munich, Hamburg, Düsseldorf and Cologne, the bank focuses on providing comprehensive advisory services and administering the assets of its private, corporate and institutional clients. This includes asset management for institutional investors, close cooperation with independent asset managers and both the concept and management of private label funds.
The partners of the bank consist of the personally liable partner, Jochen Lucht, and the partners, Michael O. Bentlage and Stephan Rupprecht. All of the bank’s capital is in the hands of private investors. Hauck & Aufhäuser considers itself a private bank that combines modernity with a strong sense of tradition. The focus of its business activities is on providing comprehensive and personalized advisory services, which form the basis for developing customized solutions. For more information visit: www.hauck-aufhaeuser.de.
For more information regarding this press release, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
Help employers find you! Check out all the jobs and post your resume.